RE:Listing application for the CSE Expected Changes in the Business of the Company
Core One is in the process of selling its operations related to the cultivation of cannabis in the United States. The Company also expects to shift production from THC CannaStripsTM at a highly regulated T&T facility to CBD CannaStripsTM at a less regulated facility. The shift from THC CannaStripsTM to CBD CannaStripsTM will also allow the Company to move away from the highly regulated and fractured marijuana market to the less regulated CBD market where the products can be sold via eCommerce to every state in the U.S. and across state lines. The Company also expects to broaden its focus away from cannabinoids and to research the adaptation of its CannaStripsTM to be used with psilocybin. In connection with these expected changes, the Company has begun to acquire Canadian assets (Rejuva and Shahcor) and investigate Canadian acquisition targets in the psilocybin space (Vocan) in order to further advance the Company’s product development efforts.